FI964212A - Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia - Google Patents

Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia Download PDF

Info

Publication number
FI964212A
FI964212A FI964212A FI964212A FI964212A FI 964212 A FI964212 A FI 964212A FI 964212 A FI964212 A FI 964212A FI 964212 A FI964212 A FI 964212A FI 964212 A FI964212 A FI 964212A
Authority
FI
Finland
Prior art keywords
pharmaceutically acceptable
compositions containing
ray contrast
containing pharmaceutically
contrast compositions
Prior art date
Application number
FI964212A
Other languages
English (en)
Swedish (sv)
Other versions
FI964212A0 (fi
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John Toner
Edward R Bacon
Tom Caulfield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of FI964212A0 publication Critical patent/FI964212A0/fi
Publication of FI964212A publication Critical patent/FI964212A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI964212A 1994-04-21 1996-10-18 Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia FI964212A (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en) 1994-04-21 1995-03-16 X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (2)

Publication Number Publication Date
FI964212A0 FI964212A0 (fi) 1996-10-18
FI964212A true FI964212A (fi) 1996-10-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964212A FI964212A (fi) 1994-04-21 1996-10-18 Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia

Country Status (9)

Country Link
EP (1) EP0756497A1 (fi)
JP (1) JPH09512029A (fi)
CN (1) CN1147206A (fi)
AU (1) AU1897795A (fi)
CA (1) CA2187019A1 (fi)
FI (1) FI964212A (fi)
HU (1) HUT76304A (fi)
NO (1) NO964451L (fi)
WO (1) WO1995028969A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (ja) * 2003-06-10 2011-04-13 味の素株式会社 Ｃｔコロノグラフィにおける消化管造影用組成物
CA2554696C (en) 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
US7507860B2 (en) 2004-04-13 2009-03-24 Pfizer Inc. Androgen modulators
CA2562672C (en) 2004-04-22 2009-09-29 Warner-Lambert Company Llc 4-cyano-phenoxy derivatives as androgen modulators
CA2570047C (en) 2004-07-08 2010-09-28 Warner-Lambert Company Llc 4-cycloalkoxy benzonitriles as androgen modulators
CN1330380C (zh) * 2005-03-18 2007-08-08 山东师范大学 一种x－射线造影剂组合物
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US11033640B2 (en) 2013-03-15 2021-06-15 The Regents Of The University Of California Enteric CT contrast material based on low-z atoms
US20160193366A1 (en) * 2013-08-16 2016-07-07 The Regents Of The University Of California Silicone-based enteric ct contrast material
CN106075476B (zh) * 2016-07-30 2019-05-31 温州市人民医院 一种造影剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (fr) * 1954-01-08 1959-05-15 Schering Corp Utilisation comme agents radio-opaques de phénoxy-acides gras polyiodés
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
CA2094893A1 (en) * 1992-05-01 1993-11-02 Carl R. Illig X-ray contrast compositions containing film-forming materials
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
FI964212A0 (fi) 1996-10-18
HUT76304A (en) 1997-07-28
CN1147206A (zh) 1997-04-09
MX9604899A (es) 1998-03-31
JPH09512029A (ja) 1997-12-02
NO964451D0 (no) 1996-10-18
EP0756497A1 (en) 1997-02-05
CA2187019A1 (en) 1995-11-02
WO1995028969A1 (en) 1995-11-02
HU9602908D0 (en) 1996-12-30
AU1897795A (en) 1995-11-16
NO964451L (no) 1996-12-18

Similar Documents

Publication Publication Date Title
TR199501447A2 (tr) Oral bilesimler.
DE59812592D1 (de) Röntgengerät
DE69423024D1 (de) Röntgengerät
FI963421A (fi) Oraalisia apuainekoostumuksia
DE69834019D1 (de) Dose
BR9508844A (pt) Composição oral
DE69520639D1 (de) Desinfizierende Zusammensetzung
BR9506536A (pt) Composição oral
ID18352A (id) Komposisi-komposisi farmasi
ZA951374B (en) Ranitidine solid dosage form
ID17561A (id) Komposisi untuk pemakaian luar
FI964212A (fi) Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia
BR9510307A (pt) Composições orais
BR9507768A (pt) Composição farmacêutica
TR199501082A2 (tr) Farmasötik formülasyonlar.
ITMI941169A0 (it) Formulazioni farmaceutiche
ID18698A (id) Komposisi farmasi
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI963299A0 (fi) Röntgenvarjoainekoostumukset, jotka sisältävät selluloosajohdannaisia
DE69512984T2 (de) Röntgengerät
BR9503633A (pt) Composição desinfetante
FI951155A0 (fi) Farmaseuttinen valmiste
NO954695D0 (no) Jod-borforbindelser egnet som röntgenkontrastmidler, og farmasöytiske forbindelser derav
ITMI962628A0 (it) Composizione farmaceutica
FI962738A (fi) Farmaseuttiset koostumukset

Legal Events

Date Code Title Description
FD Application lapsed